Genesis Therapeutics
Burlingame, CA
Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in a molecular generation and property prediction. The company was founded in 2019 and based in South San Francisco, California.
genesistherapeutics.aiCompany Details
Founded
- 2019
Employees
- Between 20 - 100 employees
Raised
- $256,100,000
Headquarters Location
- Burlingame, CA
Public
- No
Acquired
- No
CEO
Evan Feinberg
Founders
- Evan FeinbergBen Sklaroff
Company Collections
These are collections Genesis Therapeutics is a part of. Click on the collection name to view similar companies.
Genesis Therapeutics' Investors
Genesis Therapeutics' Industries
Genesis Therapeutics' Tech Stack
Genesis Therapeutics Headquarters Location
Chapin Ave, Burlingame, CA 94010
Total Amount Raised: $256,100,000
Genesis Therapeutics' Investors
Genesis Therapeutics Funding Rounds
Series B
$200,000,000
Series B Investors
Andreessen HorowitzBlackrockT. Rowe PriceRadical VenturesFidelityRock Springs CapitalMenlo VenturesGreen D VenturesNVenturesSeries A
$52,000,000
Series A Investors
Rock Springs CapitalharpoonMark LeslieAndreessen HorowitzFelicisOpen Field CapitalUlu VenturesJeffrey RothschildPropagator VenturesRadical VenturesMenlo VenturesJazz Venture PartnersT. Rowe PriceSeed
$4,100,000
Seed Investors
Andreessen HorowitzFelicis
Funding info provided by Diffbot.
Genesis Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Genesis Therapeutics.